Pulmonary hypertension treatment cost in Thailand typically runs between $35,000 / 1,295,000฿ and $65,000 / 2,405,000฿ for advanced regenerative protocols. Essential diagnostics, such as a consultation with a cardiologist, range from $100 / 3,700฿ to $200 / 7,400฿. Total expenses depend on the severity of the arterial pressure and the chosen therapeutic approach. Patients can expect 40-70% savings compared to the US. Most specialized care is concentrated in Bangkok and Phuket.
Typical Pulmonary Hypertension Treatment Costs in Thailand
Bookimed Expert Insight: Patients seeking innovative care for vascular conditions benefit from Thailand's advanced regenerative medicine centers. For instance, The Demarest Clinic in Phuket utilizes AABB-certified processes for cellular therapies. Complex cases requiring multi-disciplinary heart care are best managed at JCI-accredited facilities like Bumrungrad International Hospital. This center treats one million patients annually with AI-driven diagnostics. For personalized cardiovascular revitalization, clinics led by pioneers like Dr. Ratanapunt Incharoensakdi offer decades of specialized cardiology expertise.
| Thailand | Türkei | Österreich | |
| Stammzellentherapie bei pulmonaler Hypertonie | von $35,000 / 1,295,000฿ | von $12,000 / 444,000฿ | von $55,000 / 2,035,000฿ |
| LDL-Apherese | - | von $1,650 / 61,050฿ | - |
Bookimed erhebt keine zusätzlichen Gebühren für Pulmonale Hypertonie-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Pulmonale Hypertonie einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Pulmonale Hypertonie-Behandlungsreise nie allein.
Dr. Piyaphon On-phoon ist auf Anti-Aging- und Regenerationsmedizin spezialisiert. Er bietet zudem Chelattherapie und Immuntherapie mit Hochdosis-Vitamin- und Nährstoffinfusionen an.
Er behandelt Erektionsstörungen und bietet Hormonersatztherapie an. Außerdem bietet er präventive Versorgung bei nichtübertragbaren Krankheiten wie Hypertonie, Arteriosklerose, Diabetes und Dyslipidämie. Er behandelt auch Hauterkrankungen und führt ästhetische Behandlungen mit Laser, HIFU, Thermage, Botox und Filler-Injektionen durch.
Dr. Sakulpaptong ist auf fortgeschrittene Echokardiographie am King Chulalongkorn Memorial Hospital spezialisiert, einem führenden Zentrum für Kardiologie in Thailand.
Pionier bei nicht-invasiven Behandlungen von Herzkrankheiten – Dr. Ratanapunt verfügt über mehr als 40 Jahre Erfahrung in der Kardiologie und hat die moderne Herzversorgung in Thailand mitgestaltet.
Senior Medical Director bei der American Clinic, Demarest, mit umfassender Führungserfahrung im Gesundheitsmanagement und in der Gesundheitspolitik.
Thailand features JCI-accredited tertiary hospitals in Bangkok equipped with advanced cardiac catheterization labs for pulmonary hypertension. Leading centers like Bumrungrad International Hospital utilize specialized cardiology units. These facilities offer complex diagnostics and regenerative therapies. Many centers serve a high volume of international patients annually.
Bookimed Expert Insight: While many choose large hospitals, specialized centers often provide niche therapies not found elsewhere. Dr. Ratanapunt Incharoensakdi founded the first specialized heart center in Thailand. His current clinic specifically focuses on regenerative cardiology. Clinically experienced doctors with over 40 years of practice often bridge the gap between traditional and innovative treatments.
Patient Consensus: Patients note it is important to choose large Bangkok referral hospitals. These centers have the specialized cardiology and pulmonology teams needed for complex catheterization and long-term medication management.
Evidence-based medications for pulmonary hypertension are routinely available and prescribed in Thailand. Specialized centers follow the Thai Pulmonary Hypertension Guidelines 2020. They offer modern therapies like phosphodiesterase type-5 inhibitors and endothelin receptor antagonists. Availability remains strongest at JCI-accredited tertiary hospitals in Bangkok.
Bookimed Expert Insight: While basic PH drugs are common, specialized treatments like prostanoids are often concentrated in high-volume Bangkok centers. Dr. Ratanapunt Incharoensakdi, who established Thailand's first heart center, has over 40 years of experience. This level of expertise is crucial because misprescribing vasodilators for the wrong PH type can be harmful.
Patient Consensus: Patients note that formal diagnosis by a specialist is essential before receiving advanced medications. They emphasize that while drugs are available, visiting major university or tertiary hospitals ensures access to the latest guideline-based programs.
International patients should seek a multidisciplinary team led by a board-certified cardiologist or pulmonologist specializing in heart failure. Specialized centers in Thailand, such as JCI-accredited Bumrungrad International Hospital, provide integrated care using advanced diagnostics like right heart catheterization and 3D echocardiography for accurate staging.
Bookimed Expert Insight: While many seek traditional care, practitioners like Dr. Ratanapunt at Longa Heart Health Medical Center bring 40+ years of expertise. Highly experienced specialists often focus on non-invasive rehabilitation protocols. These veteran doctors typically manage complex cases that move beyond standard drug therapy to include cardiac rehabilitation programs.
Patient Consensus: Patients note it is essential to prepare echocardiogram records before arrival. Many emphasize choosing clinics with dedicated international departments for seamless translation during complex medical consultations.
Thailand performs pulmonary endarterectomy (PEA) for chronic thrombo-embolic pulmonary hypertension (CTEPH) at highly specialized tertiary centers. Leading institutions in Bangkok like King Chulalongkorn Memorial Hospital and Bumrungrad International Hospital manage complex cases. Success requires experienced cardiothoracic teams and advanced vascular diagnostic capabilities.
Bookimed Expert Insight: While Thailand has over 150 clinics, PEA remains concentrated in a few high-volume centers. Dr. Ratanapunt Incharoensakdi, who founded Thailand's first specialized heart center, highlights the importance of institutional experience. Patients should prioritize hospitals with established pulmonary hypertension programs over general cardiac clinics. These centers often manage over 1 million patients annually, ensuring robust perioperative support structures like ECMO.
Patient Consensus: Patients note that getting a correct diagnosis and early referral is often the most difficult step. They emphasize choosing a center with a dedicated CTEPH program rather than a standard hospital.
Language barriers in Thailand do not compromise care for English speakers at top international hospitals. Facilities like Bumrungrad International Hospital serve over 1 million patients annually using bilingual staff. Most accredited centers provide dedicated translation services and documentation to ensure precise medication dosing and safety.
Bookimed Expert Insight: While doctors at major Bangkok centers are fluent, communication gaps often occur during pharmacy handovers. Select clinics like PrimeCare Bkk that use dedicated bilingual teams for the entire journey. This ensures that critical follow-up instructions and dosage timing remain accurate after leaving the consultation room.
Patient Consensus: Patients note that primary doctors speak excellent English, but nursing and administrative staff may use simpler terms. It is helpful to bring a written medical summary to bridge any technical gaps during coordination.